Table 1.
Variables | EFS | OS | |||
---|---|---|---|---|---|
χ2 | P-value | χ2 | P-value | ||
Chemotherapy-only group | |||||
SPNS1 (high vs. low) | 0.635 | 0.425 | 0.131 | 0.718 | |
SPNS2 (high vs. low) | 11.465 | 0.001 | 4.784 | 0.029 | |
SPNS3 (high vs. low) | 7.618 | 0.006 | 4.599 | 0.023 | |
Allo-HSCT group | |||||
SPNS1 (high vs. low) | 0.137 | 0.711 | 0.034 | 0.854 | |
SPNS2 (high vs. low) | 0.033 | 0.856 | 1.760 | O.185 | |
SPNS3 (high vs. low) | 0.135 | 0.714 | 10.207 | 0.001 |
Allo-HSCT allogeneic hematopoietic stem cell transplantation, EFS event-free survival, OS overall survival